液体活检的当前趋势 追踪分子乳腺癌向疗法的抵抗性
Richard Tancredi1, Navid Sobhani2, Martina Catalano3
1Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, 26100 Cremona, Italy.
Genes
|April 26, 2025
概括
液体活检为监测乳腺癌 (BC) 进展提供了一种不那么侵入性的方法. 这种基于血液的方法克服了传统针活检的局限性,提高了准确性和患者护理.
科学领域:
- 在瘤学瘤学.
- 分子诊断学 分子诊断
- 生物化学 生物化学
背景情况:
- 乳腺癌 (BC) 是全球女性癌症死亡的主要原因.
- 目前对BC进展的监测方法有局限性.
- 越来越需要准确的,不那么侵入性的监测技术.
研究的目的:
- 审查乳腺癌监测液体活检方面的进展.
- 突出BC液体活检的优势和挑战.
- 讨论液体活检在改善患者结果方面的潜力.
主要方法:
- 审查关于液体活检技术的当前文献.
- 分析液体活检在乳腺癌检测和监测中的应用.
- 在BC中讨论无细胞核酸和循环瘤DNA.
主要成果:
- 液体活检检测BC患者血液中的核酸和无细胞DNA.
- 它提供了一个不那么侵入性的替代针活检.
- 它解决了瘤异质性,并提供了对转移潜力的洞察力.
结论:
- 液体活检代表了乳腺癌管理的重大进步.
- 它为癌症监测提供了一种更全面,更少侵入性的方法.
- 需要进一步的研究来克服现有的挑战,并优化其临床使用.
更多相关视频
05:26A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
Published on: September 16, 2022
3.8K
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
10.3K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
